Showing results (551-560 of 649) with videos related to
Sort By:
Pageof 65
The Journal of Infectious Diseases|July 12, 2012
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfectionDonald D Anthony, Sara J Conry, Kathy Medvik, et al.Nature Communications|September 17, 2024
Frontoparietal network topology as a neural marker of musical perceptual abilitiesM Lumaca, P E Keller, G Baggio, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2016
Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune EvasionDominic Paquin-Proulx, Anna Gibbs, Susanna M Bächle, et al.The Journal of General Virology|July 9, 2010
Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion proteinMalin K Sandberg, Huda Al-Doujaily, Christina J Sigurdson, et al.AIDS (London, England)|May 11, 2016
Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infectionsSusanna M Bächle, David F G Malone, Marcus Buggert, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversityJ K Sandberg, L Franksson, J Sundbäck, et al.AIDS (London, England)|July 11, 2009
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expressionJennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, et al.AIDS (London, England)|June 25, 2014
Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in UgandaProssy Naluyima, Michael A Eller, Oliver Laeyendecker, et al.Scandinavian Journal of Immunology|January 5, 2011
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionC Kuylenstierna, J E Snyder-Cappione, C P Loo, et al.European Journal of Immunology|October 30, 2018
Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17Michał J Sobkowiak, Haleh Davanian, Robert Heymann, et al.Pageof 65